BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2904203)

  • 1. Comparison of topical timolol vs betaxolol on cardiopulmonary exercise performance in healthy volunteers.
    Dickstein K; Hapnes R; Aarsland T; Kristianson K; Viksmoen L
    Acta Ophthalmol (Copenh); 1988 Aug; 66(4):463-6. PubMed ID: 2904203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lack of efficacy of topical beta-blockers, timolol and betaxolol on intraocular pressure in Nigerian healthy volunteers.
    Olateju SO; Ajayi AA
    Eye (Lond); 1999 Dec; 13 ( Pt 6)():758-63. PubMed ID: 10707140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cardiovascular, pulmonary, and ocular hypotensive effects of 0.2% brimonidine.
    Nordlund JR; Pasquale LR; Robin AL; Rudikoff MT; Ordman J; Chen KS; Walt J
    Arch Ophthalmol; 1995 Jan; 113(1):77-83. PubMed ID: 7826297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Corneal sensitivity after single doses of timolol, betaxolol or placebo in persons with healthy eyes--a randomized, prospective double-blind study].
    Höh H
    Fortschr Ophthalmol; 1988; 85(2):132-8. PubMed ID: 2899042
    [No Abstract]   [Full Text] [Related]  

  • 5. Retrobulbar arterial hemodynamic effects of betaxolol and timolol in normal-tension glaucoma.
    Harris A; Spaeth GL; Sergott RC; Katz LJ; Cantor LB; Martin BJ
    Am J Ophthalmol; 1995 Aug; 120(2):168-75. PubMed ID: 7639300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additive effect of betaxolol and epinephrine in primary open angle glaucoma.
    Allen RC; Epstein DL
    Arch Ophthalmol; 1986 Aug; 104(8):1178-84. PubMed ID: 2874783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.
    Nordmann JP; Mertz B; Yannoulis NC; Schwenninger C; Kapik B; Shams N;
    Am J Ophthalmol; 2002 Jan; 133(1):1-10. PubMed ID: 11755834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Betaxolol and timolol. A comparison of efficacy and side effects.
    Berry DP; Van Buskirk EM; Shields MB
    Arch Ophthalmol; 1984 Jan; 102(1):42-5. PubMed ID: 6367723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of betaxolol and timolol in open angle glaucoma and ocular hypertension.
    Feghali JG; Kaufman PL; Radius RL; Mandell AI
    Acta Ophthalmol (Copenh); 1988 Apr; 66(2):180-6. PubMed ID: 2898859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of topical beta-blockers during exercise.
    Atkins JM; Pugh BR; Timewell RM
    Am J Ophthalmol; 1985 Feb; 99(2):173-5. PubMed ID: 3970121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Timolol, betaxolol and befunolol in the treatment of glaucoma. Study of their bronchopulmonary effects].
    Pecori-Giraldi J; Collini S; Planner-Terzaghi A; Arrico L; Grechi G
    Fortschr Ophthalmol; 1988; 85(3):235-8. PubMed ID: 2905321
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of ophthalmic administration of S-596 (Arotinolol) on intraocular pressure and haemodynamics in health volunteers: comparison with timolol.
    Nakashima M; Uematsu T; Takiguchi Y; Hashimoto H; Watanabe I; Morioka S; Hibino T
    Eur J Clin Pharmacol; 1985; 28(4):391-6. PubMed ID: 2411566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing therapy from timolol to betaxolol. Effect on intraocular pressure in selected patients with glaucoma. Timolol-Betaxolol Study Group.
    Vogel R; Tipping R; Kulaga SF; Clineschmidt CM
    Arch Ophthalmol; 1989 Sep; 107(9):1303-7. PubMed ID: 2571326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of topical betaxolol, timolol, and placebo on pulmonary function in asthmatic bronchitis.
    Schoene RB; Abuan T; Ward RL; Beasley CH
    Am J Ophthalmol; 1984 Jan; 97(1):86-92. PubMed ID: 6141730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ophthalmic beta-blocking agents.
    Lesar TS
    Clin Pharm; 1987 Jun; 6(6):451-63. PubMed ID: 2891463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical beta-blockade with intrinsic sympathomimetic activity offers no advantage for the respiratory and cardiovascular function of elderly people.
    Diggory P; Cassels-Brown A; Fernandez C
    Age Ageing; 1996 Nov; 25(6):424-8. PubMed ID: 9003876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-masked, randomized, 1-year study comparing the corneal effects of dorzolamide, timolol, and betaxolol. Dorzolamide Corneal Effects Study Group.
    Lass JH; Khosrof SA; Laurence JK; Horwitz B; Ghosh K; Adamsons I
    Arch Ophthalmol; 1998 Aug; 116(8):1003-10. PubMed ID: 9715679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy of betaxolol-brinzolamide and timolol-dorzolamide as suppressors of aqueous humor flow in human subjects.
    Brubaker RF; Ingram CJ; Schoff EO; Nau CB
    Ophthalmology; 2000 Feb; 107(2):283-7. PubMed ID: 10690826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of short- and long-term effects of betaxolol and timolol on human retinal circulation.
    Yoshida A; Ogasawara H; Fujio N; Konno S; Ishiko S; Kitaya N; Kagokawa H; Nagaoka T; Hirokawa H
    Eye (Lond); 1998; 12 ( Pt 5)():848-53. PubMed ID: 10070522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison in healthy volunteers of the systemic beta adrenergic receptor blockade by beta blockader eye drops].
    de Dieuleveult C; Queinnec MC; Pinaud M; Souron R
    Ann Fr Anesth Reanim; 1989; 8(1):46-50. PubMed ID: 2565697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.